Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CryoCloud logo — Accelerating cryo-EM with our cloud-native data platform

CryoCloud

Accelerating cryo-EM with our cloud-native data platform

Founded 2021 The Netherlands The Netherlands 11 employees Seed Total: $2.50M Biotechnology, Cloud Infrastructure +1

General Information

Company Name CryoCloud
Founded Year 2021
Location The Netherlands The Netherlands
Employees 11
Industries Biotechnology, Cloud Infrastructure, Internet
Funding Stage Seed
Business Model SaaS, B2B, Platform
Revenue Model Subscription, Usage Based, Tiered Pricing
Offices as of Oct 2026
Utrecht, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with CryoCloud. To contact CryoCloud, visit cryocloud.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CryoCloud compare?

A PDF of CryoCloud and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CryoCloud soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Oct 23, 2026

CryoCloud has released CryoCloud v3.0, a major update featuring a new 3D Refinement engine and CryoEdge infrastructure tool.

Feature Release Oct 20, 2026

CryoCloud launched a new feature on its Class3D job page, enabling side-by-side comparison of 3D maps in a single window to inspect differences.

Growth Metrics Oct 16, 2026

CryoCloud's algorithms processed 2,755 raw movies to 1.32 M picked particles in 1.2 hours.

Get alerts when CryoCloud shows new signals

About CryoCloud

CryoCloud, founded in 2021 and headquartered in The Netherlands, champions the intersection of Biotechnology, Cloud Infrastructure, and the Internet with its innovative cloud-native platform for cryo-EM data analysis. Their slogan, "Accelerating cryo-EM with our cloud-native data platform," accurately reflects the company's mission to democratize and streamline cryo-EM processes.

With no local hardware or complex software installations required, CryoCloud provides a seamless, intuitive experience for users, offering features like live data uploads and scalable cloud storage. It's designed to suit both newcomers and advanced structural biology labs, facilitating rapid end-to-end analysis.

In its latest funding round, CryoCloud secured a €2.00M seed investment on 01 May 2025, backed by investors such as Nina Ventures, Value Creation Capital, ROM Utrecht Region, and Utrecht Health Seed Fund. This investment highlights confidence in CryoCloud's potential to remove technical barriers and revolutionize cryo-EM data analysis.

Business keywords: cryo-EM, cloud-native platform, structural biology, protein structure determination, cloud storage, image analysis solutions, single particle analysis, tomography, drug discovery, end-to-end analysis, X-ray crystallography, live data uploads, automated analysis

Services & Products

cryo-EM data processing
streamlined workflows
data storage and management
real-time data upload
3D mapping
automated algorithms
secure archiving
collaborative tools

Target Customers

academia biotech companies pharmaceutical companies contract research organizations scientific facilities

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed €2.00M 4
Nina Ventures Value Creation Capital ROM Utrecht Region
Nina Ventures, Value Creation Capital +2
01 May 2025
Seed €500.00K 3
Nina Ventures ROM Utrecht Region Utrecht Health Seed Fund
Nina Ventures, ROM Utrecht Region +1
01 Feb 2024

Latest News

View All
Wagestream secures £300M debt financing, DoorDash's £2.4B Deliveroo acquisition, and European tech f... — Tech
Wagestream secures £300M debt financing, DoorDash's £2.4B Deliveroo acquisition, and European tech funding falls 42% in April
Tech Nov 23, 2025
Beyond the AI buzz: Nina Capital’s critical view on healthtech hype — Tech
Beyond the AI buzz: Nina Capital’s critical view on healthtech hype
Tech Aug 06, 2025
Dutch biotech CryoCloud raises €2M to enhance machine learning for drug discovery — Tech
Dutch biotech CryoCloud raises €2M to enhance machine learning for drug discovery
Tech May 06, 2025

CryoCloud Alternatives & Competitors

View All Alternatives
CryoCloud vs
Culture Biosciences
Culture Biosciences United States

Grow Smarter with Culture

Series C
67 employees
Automation, Biotechnology
CryoCloud vs
Lifebit
Lifebit United States

We built the Federated Trusted Research Environment for the world's most sensitive health data.

Series B
67 employees
AI, Biotechnology
CryoCloud vs
Impossible Cloud
Impossible Cloud Germany

Europe's sovereign cloud storage

72 employees
Cloud Infrastructure, Internet
View all alternatives

FAQ About CryoCloud

Accelerating cryo-EM with our cloud-native data platform
CryoCloud was founded in 2021.
CryoCloud is headquartered in The Netherlands. As of Oct 2026, it also has offices in Utrecht, The Netherlands.
CryoCloud operates in Biotechnology, Cloud Infrastructure and Internet. Its work centres on cryo-EM, cloud-native platform, structural biology and protein structure determination. Its customers include academia, biotech companies and pharmaceutical companies.
CryoCloud has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
CryoCloud has approximately 11 employees.
CryoCloud has completed 2 funding rounds, raising a total of $2.50M. The latest funding stage is Seed.
CryoCloud offers: cryo-EM data processing, streamlined workflows, data storage and management, real-time data upload, 3D mapping, automated algorithms, secure archiving, collaborative tools.
Top alternatives and competitors to CryoCloud include Culture Biosciences, Lifebit, Impossible Cloud, OVHcloud, Watershed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CryoCloud and Culture Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CryoCloud, https://bouncewatch.com/company/cryocloud, updated 18 August 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes